Tower Research Capital (TRC)’s Apexigen, Inc. WarrantApexigen, Inc. Warrant APGNW Stock Holding History

Tower Research Capital (TRC)’s Portfolio APGNW Stock Details APGNW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-58	Closed	-$2	–	6427
2023 Q2	$2	Hold	58	–	–	﹤0.01%	5997
2023 Q1	$0	Hold	58	–	–	﹤0.01%	6565
2022 Q4	$0	Hold	58	–	–	﹤0.01%	6649
2022 Q3	$0	Buy	+58	New	+$14	﹤0.01%	6746

Other funds holding APGNW

RCM

Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return

Tower Research Capital (TRC)'s APGNW Position: Q3 2023 in Review

Tower Research Capital (TRC) sold out of Apexigen, Inc. WarrantApexigen, Inc. Warrant (APGNW) in Q3 2023, closing a stake of 58 shares — an estimated $2 sold.

Tower Research Capital (TRC) first reported a position in APGNW in Q3 2022 and held it in 4 quarters. The position peaked at $2 in Q2 2023. 1 fund tracked by Wall St. Rank holds APGNW as of Q3 2023.

Tower Research Capital (TRC) reported no remaining Apexigen, Inc. WarrantApexigen, Inc. Warrant position as of Q3 2023 after selling out during the quarter.
Tower Research Capital (TRC) sold 58 Apexigen, Inc. WarrantApexigen, Inc. Warrant shares in Q3 2023, an estimated $2.
Tower Research Capital (TRC) first reported a position in Apexigen, Inc. WarrantApexigen, Inc. Warrant in Q3 2022 and held it in 4 quarters.
Tower Research Capital (TRC)'s Apexigen, Inc. WarrantApexigen, Inc. Warrant position peaked at $2 in Q2 2023.
1 fund tracked by Wall St. Rank held Apexigen, Inc. WarrantApexigen, Inc. Warrant as of Q3 2023.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2023, filed 14 Nov 2023.